Efficacy and Safety of TurmXTRA® 60N in Delayed Onset Muscle Soreness in Healthy, Recreationally Active Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial

BACKGROUND: Delayed onset of muscle soreness (DOMS) and its physiological consequences influenced an individual's adherence to an exercise routine. OBJECTIVE: This study aimed to evaluate the efficacy, safety, and tolerability of TurmXTRA® 60N (WDTE60N) on DOMS compared to placebo in recreation...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanawala, Shefali, Shah, Rajat, Karlapudi, Vasu, Desomayanandam, Prabakaran, Bhuvanendran, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374544/
https://www.ncbi.nlm.nih.gov/pubmed/35966736
http://dx.doi.org/10.1155/2022/9110414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374544/
https://www.ncbi.nlm.nih.gov/pubmed/35966736
http://dx.doi.org/10.1155/2022/9110414

Ejemplares similares